Literature DB >> 20512482

[Intrathecal baclofen therapy in ambulatory patients with spastic hemiparesis following stroke. Short report of two cases].

S Kästner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512482     DOI: 10.1007/s00115-010-3029-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  19 in total

1.  Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.

Authors:  Saud A Sadiq; Gary C Wang
Journal:  J Neurol       Date:  2005-11-22       Impact factor: 4.849

2.  Effect on ambulation of continuous intrathecal baclofen infusion.

Authors:  P C Gerszten; A L Albright; M J Barry
Journal:  Pediatr Neurosurg       Date:  1997-07       Impact factor: 1.162

3.  Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

Authors:  D M Simpson; D N Alexander; C F O'Brien; M Tagliati; A S Aswad; J M Leon; J Gibson; J M Mordaunt; E P Monaghan
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

4.  Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury.

Authors:  R Becker; O Alberti; B L Bauer
Journal:  J Neurol       Date:  1997-03       Impact factor: 4.849

Review 5.  Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.

Authors:  E Montané; A Vallano; J R Laporte
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

6.  Intrathecal baclofen for spastic hypertonia from stroke.

Authors:  J M Meythaler; S Guin-Renfroe; R C Brunner; M N Hadley
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

7.  Late motor recovery is influenced by muscle tone changes after stroke.

Authors:  Rita Formisano; Patrizia Pantano; M Gabriella Buzzi; Vincenzo Vinicola; Francesca Penta; Piero Barbanti; Gian Luigi Lenzi
Journal:  Arch Phys Med Rehabil       Date:  2005-02       Impact factor: 3.966

8.  Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.

Authors:  Cindy B Ivanhoe; Gerard E Francisco; John R McGuire; Thyagarajan Subramanian; Samuel P Grissom
Journal:  Arch Phys Med Rehabil       Date:  2006-11       Impact factor: 3.966

9.  Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.

Authors:  Allison Brashear; Mark F Gordon; Elie Elovic; V Daniel Kassicieh; Christina Marciniak; Mai Do; Chia-Ho Lee; Stephen Jenkins; Catherine Turkel
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

10.  Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait.

Authors:  Olivier Rémy-Néris; Vincent Tiffreau; Stéphane Bouilland; Bernard Bussel
Journal:  Arch Phys Med Rehabil       Date:  2003-05       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.